title: The effect of montelukast, budesonide alone, and in combination on exercise-induced bronchoconstriction.
authors.forename: MyLinh
authors.initials: M
authors.lastname: Duong
authors.forename: Reshma
authors.initials: R
authors.lastname: Amin
authors.forename: Adrian J
authors.initials: AJ
authors.lastname: Baatjes
authors.forename: Fiona
authors.initials: F
authors.lastname: Kritzinger
authors.forename: Ying
authors.initials: Y
authors.lastname: Qi
authors.forename: Zahida
authors.initials: Z
authors.lastname: Meghji
authors.forename: Wendy
authors.initials: W
authors.lastname: Lou
authors.forename: Hartmut
authors.initials: H
authors.lastname: Grasemann
authors.forename: Paul M
authors.initials: PM
authors.lastname: O'Byrne
authors.forename: Padmaja
authors.initials: P
authors.lastname: Subbarao
mesh_terms: D000085:Acetates / Q000008:administration & dosage / Q000627:therapeutic use*; D000280:Administration, Inhalation; D000293:Adolescent; D000328:Adult; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001250:Asthma, Exercise-Induced / Q000188:drug therapy* / Q000378:metabolism; D019819:Budesonide / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D003521:Cyclopropanes; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D020024:Leukotriene Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D010919:Placebos; D011804:Quinolines / Q000008:administration & dosage / Q000627:therapeutic use*; D018077:Receptors, Leukotriene / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D013440:Sulfides
chemical_list: D000085:Acetates; D018927:Anti-Asthmatic Agents; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D010919:Placebos; D011804:Quinolines; D018077:Receptors, Leukotriene; D013440:Sulfides; D019819:Budesonide; C083169:leukotriene D4 receptor; C093875:montelukast